The Physicians' Services Incorporated Foundation   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: North York ON Canada (1970)

Organization Overview

First Clinical Trial
2001
NCT00213226
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The Physicians' Services Incorporated Foundation

Active Ingredients

Drugs in Phase 4 Trials (10)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

acetylsalicylic acid (aspirin) (1 trial)

clonidine (catapres) (1 trial)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)

itraconazole (sporanox) (1 trial)

levocarnitine (carnitor) (1 trial)

morphine (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

tranexamic acid (cyklokapron) (2 trials)

urea (3 trials)

Drugs in Phase 3 Trials (26)

acetylcysteine (mucomyst) (2 trials)

alteplase (Activase) (1 trial)

bevacizumab (avastin) (1 trial)

cefazolin (ancef) (3 trials)

celecoxib (celebrex) (1 trial)

ciprofloxacin (cipro) (2 trials)

desmopressin (ddavp) (1 trial)

desogestrel (Mercilon) (1 trial)

dornase alfa (pulmozyme) (1 trial)

doxycycline (vibramycin) (2 trials)

ethinyl estradiol (Estinyl) (1 trial)

fesoterodine (toviaz) (1 trial)

magnesium sulfate (Tis-U-Sol) (1 trial)

metoclopramide (reglan) (1 trial)

metronidazole (flagyl) (2 trials)

minocycline (minocin) (1 trial)

nitric acid (1 trial)

oxytocin (syntocinon) (1 trial)

pantoprazole (protonix) (1 trial)

pregabalin (lyrica) (1 trial)

ranibizumab (lucentis) (1 trial)

rifampin (3 trials)

ringer's lactate (1 trial)

risedronate (actonel) (1 trial)

sodium chloride (3 trials)

teriparatide (1 trial)

Drugs in Phase 2 Trials (11)

anidulafungin (eraxis) (1 trial)

atorvastatin (lipitor) (1 trial)

carbon monoxide (2 trials)

domperidone (1 trial)

icosapent ethyl (vascepa) (1 trial)

levobupivacaine (chirocaine) (1 trial)

meropenem (merrem) (1 trial)

piperacillin (pipracil) (1 trial)

rosuvastatin (crestor) (2 trials)

tazobactam (Zosyn) (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Other Trials (10)

autologous microbiome (1 trial)

chlorhexidine (hibitane) (1 trial)

corticotropin (acthar) (1 trial)

isopropyl alcohol (1 trial)

ketamine (ketalar) (1 trial)

methylene blue (proveblue) (1 trial)

sitagliptin (januvia) (1 trial)

trimethoprim (1 trial)

vancomycin (Vancocin) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Anemia, Sickle Cell (Phase 3)

Asthma (Phase 2)

Atrial Fibrillation (Phase 2)

Blood Loss, Surgical (Phase 4)

Bone Neoplasms (Phase 3)

Bronchiolitis (Phase 3)

Cardiomyopathies (Phase 4)

Cardiovascular Diseases (Phase 4)

Communicable Diseases (Phase 2)

Critical Illness (Phase 2)

Cross Infection (Phase 2)

Cystic Fibrosis (Phase 4)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Depressive Disorder, Treatment-Resistant (Phase 3)

Diarrhea (Phase 3)

Dystocia (Phase 3)

Edema (Phase 3)

Emergencies (Phase 3)

Empyema (Phase 3)

Empyema, Pleural (Phase 3)

Enteritis (Phase 3)

Enterocolitis (Phase 3)

Enterocolitis, Pseudomembranous (Phase 3)

Femoral Fractures (Phase 3)

Fever (Phase 2)

Fibrosis (Phase 4)

Fractures, Bone (Phase 3)

Gastroschisis (Phase 3)

Heart Diseases (Phase 2)

Heart Valve Diseases (Phase 2)

Hemorrhage (Phase 4)

Hypertriglyceridemia (Phase 2)

Ileus (Phase 2)

Infections (Phase 3)

Influenza, Human (Phase 2)

Kidney Diseases (Phase 3)

Macular Edema (Phase 3)

Migraine Disorders (Phase 3)

Nocturia (Phase 3)

Osteoarthritis (Phase 3)

Osteoporosis (Phase 3)

Papilloma (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Ventilator-Associated (Phase 2)

Recurrence (Phase 3)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 3)

Respiratory Tract Infections (Phase 2)

Shock (Phase 3)

Shock, Septic (Phase 3)

Spinal Cord Injuries (Phase 3)

Systemic Inflammatory Response Syndrome (Phase 2)

Thrombosis (Phase 2)

Urinary Tract Infections (Phase 3)

Urolithiasis (Phase 3)

Venous Thrombosis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 52
  • # of Trial APIs: 57